Study of Pegylated Alfa Interferon, Sunitinib and Tarceva in Patients With Metastatic RCC

NCT00522249 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped PI decision

Conditions

Carcinoma, Renal Cell

Interventions

DRUG: Pegylated Alfa Interferon
DRUG: sunitinib
DRUG: erlotinib

Sponsor

The Methodist Hospital Research Institute

Collaborators

[object Object]